Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control Trial

To see complete record on, please visit this link

Id: NCT03431285

Organisation Name: Imam Abdulrahman Bin Faisal University

Overal Status: Unknown status

Start Date: January 1, 2018

Last Update: February 20, 2018

Lead Sponsor: Imam Abdulrahman Bin Faisal University

Brief Summary: Investigators hypothesize that administration of ketamine for pain relief in sickle cell patients with vaso-occlusive crisis early on will lead to a more rapid improvement in pain score and less narcotic requirement.

  • Sickle Cell Crisis

Total execution time in seconds: 0.19094705581665